RPS6KA3 and neurodegenerative disease: According to the results obtained from these studies, inhibition of MSK1 and RSK2 as the key regulatory kinases of neural cell proliferation could be considered as a treatment in order to prevent the development of neurodegenerative diseases and stop the progression of these diseases, and most importantly to help maintenance of LTP.